Keyphrases
COVID-19
100%
United States
56%
Vaccine Effectiveness
52%
Health Personnel
50%
Multidrug-resistant Organisms
38%
Hospitalization
31%
Clostridium Difficile Infection
27%
COVID-19 Pandemic
23%
MRNA Vaccine
23%
Clostridioides Difficile
22%
COVID-19 Vaccine
22%
Confidence Interval
21%
Hospitalized Patients
21%
Virus
20%
Infection Prevention
18%
Difficile
18%
COVID-19 Hospitalization
17%
Personal Protective Equipment
16%
Immunocompetent Adult
15%
Urinary Tract Infection
15%
Influenza
15%
Risk Factors
15%
Coronavirus Disease (COVID)
14%
Fecal Microbiota Transplantation
14%
Intensive Care Unit
13%
Healthcare-associated Infections
13%
Vaccination
13%
Monovalent Cations
13%
Omicron Variant
12%
Severe Acute Respiratory Syndrome
12%
Coronavirus
12%
Immunocompromised Condition
11%
Antimicrobial Stewardship
11%
Antimicrobial Resistance
11%
Disease Severity
10%
COVID-19 Vaccination
10%
Gut Microbiome
10%
Coronavirus Disease 2019 Vaccine
10%
Unvaccinated
10%
Healthcare Epidemiology
9%
2-dose
9%
COVID-19-associated Hospitalization
8%
Immunocompromised Patients
8%
US States
8%
Dental Health Care
8%
Quantitative PCR
8%
US Adults
8%
Vaccine against COVID-19
8%
Test-negative Design
8%
Pfizer-BioNTech Vaccine
8%
Medicine and Dentistry
COVID-19
85%
Infection
50%
Severe Acute Respiratory Syndrome Coronavirus 2
45%
Diseases
19%
COVID-19 Vaccine
18%
Messenger RNA
18%
Virus
17%
Cohort Effect
16%
Infection Prevention
16%
Personal Protective Equipment
14%
Antiinfective Agent
14%
Enzyme Immunoassay
13%
Peptoclostridium difficile
13%
Healthcare Associated Infection
13%
Fecal Microbiota Transplantation
12%
Clostridium Difficile Infection
11%
Infectious Disease
11%
Omicron Coronavirus Variant
10%
Pathogen
9%
Pandemic
8%
Microbiome
8%
mRNA Vaccine
7%
Diarrhea
7%
Virus Nucleocapsid
7%
COVID-19 Vaccination
7%
Transplantation
7%
Antibiotic Resistance
7%
RNA Vaccine
7%
Emergency Department
7%
Urinary Tract Infection
6%
Artificial Respiration
6%
Diagnosis
6%
Disease Severity
6%
Hospital Infection
6%
Health Care
6%
Randomized Controlled Trial
6%
Immunocompromised Patient
5%
Tertiary Care
5%
Immunosuppressive Treatment
5%
Influenza Vaccine
5%
Logistic Regression Analysis
5%